Gene therapy for patients with cancer began in earnest in the USA, starting with the first administration of tumor necrosis factor (TNF) gene-transferred tumor-infiltrating lymphocytes to patients with malignant melanoma in 1989. This evidence concerns the gene TNF and cancer.